CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma	classic Hodgkin lymphoma	Not yet recruiting	Phase 1	2026-05-20		NCT07575893

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Memorial Sloan Kettering Cancer Center	753
New York Medical College	28
University of North Carolina	30

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials